EV Biologics Inc (YECO)
0.6021
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
EV Biologics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | -5.78% |
| December 31, 2016 | -124.7% |
| September 30, 2016 | -101.2% |
| June 30, 2016 | -1.12K% |
| March 31, 2016 | 22.72% |
| December 31, 2015 | 16.65% |
| September 30, 2015 | 26.82% |
| June 30, 2015 | 19.66% |
| Date | Value |
|---|---|
| March 31, 2015 | 19.60% |
| December 31, 2014 | 15.72% |
| September 30, 2014 | 20.11% |
| June 30, 2014 | 25.99% |
| March 31, 2014 | 25.82% |
| December 31, 2013 | 20.68% |
| September 30, 2013 | 23.62% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |